NorthWest Biotherapeutics Inc (NWBO)

[AVII77]

.... while they’re presenting data that indicates a cure for 20-30% of all GBM diagnoses.

I don't know. Results look consistent with the Standard of Care (Stupp Protocol).
Here's a dataset UCLA researchers used as a comparator (from a KaiserP database).

The DCVax trial is very likely heavily weighted with RPA Class III and IV patients.

The blue line below is the Stupp protocol (chemorad followed by maintenance Chemo.)

If you add DCVax to that and get the same results doesn't that suggest DCVax does nothing?

Or, using your words, the Stupp protocol "cures 20-30%"